Statins, which are used in the treatment of atherosclerosis result in an increase in PPARγ activity by activating extracellular signal-regulated kinase (ERK) 1/2 and p38 mitogen-activated protein kinase (MAPK) pathways [49]. The gene discussed is PPARG; the disease is atherosclerosis.